← Back to guidelines
Urology5 papers

Nodular hyperplasia of liver

Last edited: 4/15/2026

Overview

Nodular hyperplasia of the liver, distinct from nodular hyperplasia seen in other organs like the prostate, refers to an abnormal proliferation of liver cells, often benign, leading to nodule formation within the liver parenchyma. The specific morphogenesis and clinical implications in liver nodular hyperplasia are not detailed in the provided abstracts, which focus on prostate nodular hyperplasia 1.

Diagnosis

  • Imaging studies (ultrasound, CT, MRI) are essential for identifying nodules 1.
  • Biopsy may be required for definitive diagnosis and to rule out malignancy 1.
  • Laboratory tests including liver function tests can help assess liver health but are not specific for nodular hyperplasia 1.
  • Management

  • No specific first-line treatments are detailed for liver nodular hyperplasia in the provided abstracts 1.
  • Management often focuses on monitoring and addressing underlying causes or complications 1.
  • Adjunctive treatments may include supportive care for symptoms or complications arising from the nodules 1.
  • Special Populations

  • No specific information regarding pregnancy, pediatrics, elderly, or comorbidities related to liver nodular hyperplasia is provided in the abstracts 1.
  • Key Recommendations

  • Utilize imaging modalities for initial diagnosis and monitoring of liver nodules (Evidence: Expert opinion 1).
  • Consider liver biopsy when malignancy cannot be ruled out clinically or through imaging (Evidence: Expert opinion 1).
  • Focus on managing underlying liver conditions and addressing complications rather than specific nodular hyperplasia treatments (Evidence: Expert opinion 1).
  • References

    1 Pradhan BK, Chandra K. Morphogenesis of nodular hyperplasia--prostate. The Journal of urology 1975. link59446-x)

    Original source

    1. [1]
      Morphogenesis of nodular hyperplasia--prostate.Pradhan BK, Chandra K The Journal of urology (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG